Rail-Splitter Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Rail-Splitter Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,649	Closed	-$236K	–	45
2016 Q3	$236K	Sell	3,649 -15,320	-81%	-$863K	0.07%	38
2016 Q2	$1.05M	Sell	18,969 -2,595	-12%	-$131K	0.25%	42
2016 Q1	$902K	Buy	21,564 +8,715	+68%	+$404K	0.22%	40
2015 Q4	$808K	Sell	12,849 -315	-2%	-$16.1K	0.19%	40
2015 Q3	$536K	Sell	13,164 -8,877	-40%	-$511K	0.15%	41
2015 Q2	$0	Buy	+22,041	New	+$1.17M	﹤0.01%	41

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rail-Splitter Capital Management's LKFT Position: Q4 2016 in Review

Rail-Splitter Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2016, closing a stake of 3,649 shares — an estimated $236K sold.

Rail-Splitter Capital Management first reported a position in LKFT in Q2 2015 and held it in 6 quarters. The position peaked at $1.05M in Q2 2016. 52 funds tracked by Wall St. Rank hold LKFT as of Q4 2016.

Rail-Splitter Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2016 after selling out during the quarter.
Rail-Splitter Capital Management sold 3,649 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2016, an estimated $236K.
Rail-Splitter Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 6 quarters.
Rail-Splitter Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.05M in Q2 2016.
52 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2016.

Based on Rail-Splitter Capital Management's 13F filing for Q4 2016, filed 8 Feb 2017.